S Hornschuh, JJ Dietrich… - AIDS Research and …, 2017 - Wiley Online Library
Human immunodeficiency virus (HIV) management of adolescents and young adults (AYAs) is particularly pertinent to sub‐Saharan Africa, where the pediatric HIV burden is marked …
O Wariri, A Ajani, MP Raymond, A Iliya, O Lukman… - BMC public health, 2020 - Springer
Background With increasing access to effective Anti-Retroviral Therapy (ART), the proportion of children who survive into later childhood with HIV has increased …
M Davtyan, D Kacanek, J Lee, C Berman… - Journal of the …, 2023 - Wiley Online Library
Introduction Decisions to disclose HIV serostatus may be complicated by internalised HIV stigma. We evaluated the association of internalised HIV stigma in biological mothers living …
BF Abegaz, TA Walle, AD Tilahun - Journal of infection and public health, 2019 - Elsevier
Background Due to the increasing availability of antiretroviral treatment, HIV infected children are living longer which points out the necessity of disclosure. And which is …
Objective: To map how the communication of the HIV infection diagnosis occurs in pediatrics. Methods: Scoping review of the 64 original articles. We selected research papers …
Disclosure of HIV status to infected children plays critical role in child health and wellbeing. This study identifies and compares child HIV disclosure barriers and facilitators in Upper …
GD Naidoo, NH McKerrow - South African Journal of Child Health, 2015 - ajol.info
Background. The introduction of antiretroviral therapy (ART) for children has resulted in survival into adolescence. This is associated with the challenge of disclosing HIV status to …
H Myburgh, E Calitz, JP Railton, C Maluleke… - Journal of the …, 2018 - Elsevier
Disclosing to a child that s/he is living with HIV is necessary to promote adherence to treatment and improve health outcomes. Facilitating disclosure between caregivers and …
S Bajaria, A Exavery, N Toroka… - AIDS Research and …, 2020 - Wiley Online Library
Background. The Tanzanian national guideline for pediatric HIV disclosure recommends beginning disclosure as early as age 4–6 years; full disclosure is recommended at the age …